N-acetylcysteine (NAC) nebulizer therapy is effective and safe as a short-term (12-week) treatment for reducing phlegm in chronic obstructive pulmonary disease (COPD), according to study findings ...

To the Editor: In the Undiagnosed COPD and Asthma Population (UCAP) trial, Aaron et al. (June 13 issue) 1 used an automated telephone service to contact more than a million persons living near one ...

The move will enable the country’s more than 100 million chronic pulmonary disease patients to access free annual check-ups.

In addition to being diagnosed more frequently in older patients, pulmonary arterial hypertension (PAH) is more frequently ...

Around 15,000 Kiwis - a number of them Māori and Pasifika - living with chronic obstructive pulmonary disease (COPD), the ...

Pulmonary nodules smaller than two centimetres can be cured if detected early As part of European Lung Cancer Week, Dr Joseba ...

Verona Pharma's Ohtuvayre offers a novel dual mechanism of action for COPD at a premium price, presenting market potential ...

What is the life expectancy of a person with a pulmonary embolism? Without prompt treatment, about a third of people with PE die, often within the first few hours at the hospital. Among those who ...

A research group from Ningbo Institute of Materials Technology and Engineering (NIMTE) of the Chinese Academy of Sciences ...

A flare-up in chronic obstructive pulmonary disease (COPD) can be predicted through changes in a person's voice, a new study ...

AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vasc ...

Riociguat is generally safe and effective for PAH patients with coexisting cardiac and metabolic conditions, a trials ...